NASDAQ · Biotechnology

WVE (WVE) Stock

$5.79 -1.78% NASDAQ: WVE Healthcare

Valuation

MetricValue
Price$5.79
Market Cap$1.11B
P/E Ratio-5.12
P/B Ratio2.26
P/S Ratio17.15
EPS (TTM)$-1.21
52-Week High$21.73
52-Week Low$5.02
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-38.78%
ROA-31.97%
ROCE-40.87%
Gross Margin-500.00%
Operating Margin-500.00%
Net Margin-2.56%
Debt/Equity0.03
Current Ratio6.47

Annual Financials (USD)

Metric20212022202320242025
Revenue$41.0M$4.0M$113.0M$108.0M$43.0M
Operating Profit$-127.0M$-163.0M$-68.0M$-110.0M$-215.0M
Net Profit$-122.0M$-162.0M$-58.0M$-97.0M$-204.0M
EPS$-2.36$-2.05$-0.54$-0.70$-1.21
Op Margin-310.1%-4459.3%-60.0%-101.9%-504.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$207.0M$146.0M$275.0M$352.0M$638.0M
Total Liabilities$175.0M$191.0M$235.0M$143.0M$112.0M
Cash$151.0M$88.0M$200.0M$302.0M$602.0M
Borrowings$30.0M$38.0M$32.0M$25.0M$18.0M

Latest News

Wave Life Sciences (WVE) Upgraded to Strong Buy: What Does It Mean for the Stock? Zacks · Jul 22, 2026 SRPT Stock Slides 10% in a Week: Is Dyne Therapeutics a Threat? Zacks · Jul 22, 2026 New Strong Buy Stocks for July 22nd Zacks · Jul 22, 2026 3 Promising Genomics Stocks to Add to Your Portfolio in 2026 Zacks · Jul 20, 2026 QURE Stock Outlook Rests on AMT-130, FDA Talks, and Cash Runway Zacks · Jul 17, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-89.0M$-128.0M$-19.0M$-151.0M$-187.0M
Investing Cash Flow$-1.0M$-3.0M$-2.0M$-2.0M$-1.0M
Financing Cash Flow$1.0M$15.0M$1.0M$18.0M$0
Net Cash Flow$-34.0M$-62.0M$112.0M$102.0M$300.0M
Free Cash Flow$-90.0M$-129.0M$-21.0M$-152.0M$-187.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-14.89%
Quick Ratio11.26
Interest Coverage—
Return 1Y-32.48%
Return 3Y37.62%
Return 5Y-5.40%

Ownership

Insiders Held15.88%
Institutions Held82.64%
Institutions Float Held98.24%
Institutional HolderSharesReport Date
RA Capital Management, L.P.26,975,5052026-03-31
GSK plc18,245,6912026-03-31
Blackrock Inc.14,117,4122026-03-31
Maverick Capital Ltd.10,161,3992026-03-31
Price (T.Rowe) Associates Inc8,704,5502026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AMLX $22.82 -5.66% -8.69 $2.54B 0.00%
ELVN $60.46 +0.32% -19.91 $4.32B 0.00%
NTLA $10.89 +2.06% -3.55 $1.22B 0.00%
ORIC $13.50 +4.41% -5.39 $1.40B 0.00%
PGEN $5.45 -1.45% -2.99 $1.94B 0.00%

About WVE

WVE is led by CEO Paul Bolno, employs 287 people, headquartered in SG, publicly traded since 2015.

WVE stock trades at $5.79 with a market capitalization of $1.11B. The stock is valued at a price-to-earnings (P/E) ratio of -5.12, price-to-book of 2.26, price-to-sales of 17.15. Over the past 52 weeks the stock has ranged between $5.02 and $21.73, and currently trades 73.4% below its 52-week high.

On profitability, WVE generates a return on equity (ROE) of -38.78%, return on capital employed of -40.87%, an operating margin of -500.00%, a net profit margin of -2.56%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides